Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 601 47 593.3 |
| 96 | EP file number | EAKZ | 11 17 1296.4 |
| 97 | EP publication number | EPN | 2382970 |
| 54 | Designation/title | TI | Stabile pharmazeutische Zusammensetzungen mit 7-substituierten-3,5-Dihydroxyheptansäuren oder 7-substituierten-3,5-Dihydroxyheptensäuren |
| 51 | IPC main class | ICM
(ICMV) | A61K 9/20 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 9/26 (2006.01), A61K 9/14 (2006.01), A61K 9/48 (2006.01), A61K 31/22 (2006.01), A61K 31/40 (2006.01) |
| 22 | DE application date | DAT | Apr 9, 2001 |
| 96 | EP application date | EAT | Apr 9, 2001 |
| 43 | Date of first publication | OT | Nov 2, 2011 |
| Date of publication of grant | PET | Jan 9, 2013 |
| 71/73 | Applicant/owner | INH | Teva Pharmaceutical Industries Ltd., Petah Tiqva, IL |
| 72 | Inventor | IN | Dorossiev, Ivo, Herzlia, IL; Fox, Michael, Tel Aviv, IL |
| 74 | Representative | VTR | D Young & Co LLP, Southhampton, Hampshire, GB |
| Address for service | | D Young & Co. LLP, SOUTHAMPTON SO14 3EB, GB |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
195916 P
Apr 10, 2000
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002382970
Searchable text:
EP000002382970
Original document:
EP000002382970B1
Searchable text:
EP000002382970B1 |
| 43 | Date of first publication | EVT | Nov 2, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Dec 16, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2025
(Show all update days)(Hide all update days)- Jan 5, 2025
- St.36: changed (technical change)
- Dec 16, 2011
- Date of the first transfer into DPMAregister
|
